89bio Inc [ETNB] stock is trading at $8.96, up 2.28%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ETNB shares have gain 12.35% over the last week, with a monthly amount glided 13.85%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, RBC Capital Mkts downgraded its rating to Sector Perform on January 12, 2024, and dropped its price target to $15. On October 10, 2023, downgrade downgraded it’s rating to Perform. UBS started tracking the stock assigning a Buy rating and suggested a price target of $36 on August 28, 2023. Evercore ISI initiated its recommendation with a Outperform and recommended $49 as its price target on June 13, 2023. Raymond James upgraded its rating to Strong Buy for this stock on May 12, 2022, and downed its price target to $12. In a note dated December 20, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $46 on this stock.
89bio Inc [ETNB] stock has fluctuated between $7.00 and $16.63 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $8.96 at the most recent close of the market. An investor can expect a potential return of 145.54% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -1298.53%, Pretax Profit Margin comes in at -1216.49%, and Net Profit Margin reading is -1234.87%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -0.6 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.74 points at the first support level, and at 8.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.34, and for the 2nd resistance point, it is at 9.72.
Ratios To Look Out For
For context, 89bio Inc’s Current Ratio is 11.65. As well, the Quick Ratio is 11.65, while the Cash Ratio is 2.34.
Transactions by insiders
Recent insider trading involved PALEKAR ROHAN, Chief Executive Officer, that happened on Nov 22 ’24 when 10000.0 shares were purchased., Le-Nguyen Quoc completed a deal on Oct 30 ’24 to sell 27955.0 shares. Meanwhile, Officer QUOC LE-NGUYEN bought 27955.0 shares on Oct 30 ’24.
